Shares of Phreesia, Inc. (NYSE:PHR – Get Free Report) crossed below its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $11.42 and traded as low as $11.34. Phreesia shares last traded at $11.41, with a volume of 1,150,642 shares trading hands.
Analyst Upgrades and Downgrades
Several analysts have recently commented on PHR shares. Raymond James Financial downgraded Phreesia from an “outperform” rating to a “market perform” rating in a research note on Tuesday, September 8th. Wall Street Zen lowered shares of Phreesia from a “buy” rating to a “hold” rating in a research report on Saturday, October 24th. Barclays increased their target price on shares of Phreesia from $10.00 to $11.00 and gave the company an “equal weight” rating in a research report on Monday, October 12th. Needham & Company LLC reaffirmed a “buy” rating and set a $14.00 price target on shares of Phreesia in a research report on Monday, August 31st. Finally, Citigroup reiterated a “market perform” rating on shares of Phreesia in a research note on Tuesday, October 20th. Eight research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $14.00.
Check Out Our Latest Analysis on PHR
Phreesia Price Performance
The business’s 50-day moving average price is $11.42 and its 200 day moving average price is $10.79. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $708.22 million, a P/E ratio of 67.12 and a beta of 0.75.
Phreesia (NYSE:PHR – Get Free Report) last issued its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). The business had revenue of $129.46 million during the quarter, compared to analysts’ expectations of $129.06 million. Phreesia had a return on equity of 5.22% and a net margin of 2.06%. The company’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the business posted $0.01 EPS. Analysts anticipate that Phreesia, Inc. will post 0.33 EPS for the current fiscal year.
Insider Activity
In related news, General Counsel Allison C. Hoffman sold 6,662 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $10.08, for a total transaction of $67,152.96. Following the completion of the sale, the general counsel directly owned 266,574 shares in the company, valued at $2,687,065.92. This represents a 2.44% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 5.20% of the company’s stock.
Institutional Investors Weigh In On Phreesia
Hedge funds have recently made changes to their positions in the company. American Century Companies Inc. bought a new position in shares of Phreesia during the 3rd quarter valued at $244,000. Algert Global LLC grew its holdings in shares of Phreesia by 14.2% in the third quarter. Algert Global LLC now owns 1,376,667 shares of the company’s stock worth $14,221,000 after acquiring an additional 171,186 shares during the period. Aquatic Capital Management LLC purchased a new stake in Phreesia during the third quarter valued at $235,000. Entropy Technologies LP purchased a new stake in Phreesia during the third quarter valued at $702,000. Finally, Jump Financial LLC lifted its holdings in Phreesia by 578.1% in the third quarter. Jump Financial LLC now owns 92,900 shares of the company’s stock valued at $960,000 after acquiring an additional 79,200 shares during the period. 92.10% of the stock is currently owned by institutional investors.
Phreesia Company Profile
Phreesia, Inc. provides software and services that help healthcare organizations manage interactions with patients. Its platform supports tasks such as patient registration and intake, appointment scheduling, payments, and communications before and after visits. Phreesia’s tools include digital and mobile options for completing forms and sharing information, as well as services designed to help providers engage patients and streamline administrative workflows. The company serves healthcare providers and organizations primarily in the United States.
Read More
- Five stocks we like better than Phreesia
- Growing Pains Versus Growth: Is BJ’s Wholesale Club a Buying Opportunity?
- Keysight Technologies: The Tollbooth on the Technology Superhighway
- Zscaler Got a Boost From Palo Alto, But Now It Has to Deliver.
- Bargain Hunting: Why Off-Price Retail Is Winning
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.
